BriaCell Therapeutics Corp. Logo

BriaCell Therapeutics Corp.

Clinical-stage immuno-oncology company developing cellular immunotherapies for cancer.

BCTX | US

Overview

Corporate Details

ISIN(s):
CA10778Y3007 (+1 more)
LEI:
Country:
United States of America
Address:
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER

Description

BriaCell Therapeutics Corp. is a clinical-stage immuno-oncology company developing a novel class of targeted cellular immunotherapies for cancer. Its lead candidate, Bria-IMT™, is a patented, off-the-shelf, cell-based therapy in a pivotal Phase 3 study for advanced metastatic breast cancer. Bria-IMT™, which has received FDA Fast Track designation, is designed to activate the patient's immune system to kill cancer cells. The company is also advancing its next-generation Bria-OTS™ platform, a personalized off-the-shelf immunotherapy that uses HLA matching to provide treatment for a broad patient population. Clinical studies for the Bria-OTS™ platform are ongoing for breast cancer, with planned expansion into prostate cancer, lung cancer, and melanoma.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-15 17:15
8-K
English ZIP 788.3 KB
2026-01-14 22:15
424B4
English ZIP 120.1 KB
2026-01-14 06:15 English ZIP 5.2 KB
2026-01-14 02:57
S-1MEF
English ZIP 117.4 KB
2026-01-13 23:13 English ZIP 165.5 KB
2026-01-13 18:07
8-A12B
English ZIP 117.9 KB
2025-12-29 22:05
8-K
English ZIP 633.5 KB
2025-12-23 15:06
FWP
English ZIP 51.6 MB
2025-12-23 14:21
S-1
English ZIP 627.4 KB
2025-12-11 22:05
10-Q
English ZIP 1.0 MB
2025-11-29 02:15
8-K
English ZIP 1.1 MB
2025-11-07 22:47 English ZIP 10.1 KB
2025-10-16 22:19 English ZIP 139.8 KB
2025-10-16 02:46
10-K
English ZIP 4.6 MB
2025-10-10 18:31 English ZIP 8.5 KB

Automate Your Workflow. Get a real-time feed of all BriaCell Therapeutics Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BriaCell Therapeutics Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BriaCell Therapeutics Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.